Home › NDC Lookup › Ingredients › Benzocaine › 82895-0857-05
🧴image loading
(from DailyMed)

Chigg Away Benzocaine 50 mg/mL Lotion, 118 mL — NDC 82895-857-05 (Billing 82895-0857-05)

by Westlake HB Pharma LLC · 118 mL in 1 BOTTLE, PLASTIC

This is a package of 118 mL of Chigg Away Benzocaine 50 mg/mL Lotion from Westlake HB Pharma LLC, no longer marketed (first marketed Jun 2022), no longer in the FDA NDC Directory, this package's marketing ended Aug 2026. It is this product's only package size.

NDC 82895-0857-05
🏷️ FDA NDC (as labeled) 82895-857-05 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 82895-857-05 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
82895 labeler · 857 product · 05 package
Package marketed since
Jun 23, 2022
Package marketing ended
Aug 31, 2026
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 8289585705 2
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Benzocaine (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0602-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0605-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0601-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0603-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0604-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0606-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Aug 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 82895-857-05
Product NDC 82895-857
11-digit billing NDC 82895085705
RxCUI 1373322
UNII U3RSY48JW5
Application # M017
SPL Set ID e21ed5f6-4076-0857-e053-2995a90a0a7c
Established class (EPC) Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity
Chemical class Allergens
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Aug 2026)
Marketing start 2022-06-23
Marketing end 2026-08-31
Route TOPICAL
Dosage form LOTION
Substance BENZOCAINE
Quick answers
  • RxCUI (RxNorm): 1373322
Why two NDCs? The FDA registers this code as 82895-857-05 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82895-0857-05. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Standardized Chemical Allergen class.

Pharmacologic class Standardized Chemical Allergen
Drug family (ATC) Local anesthetics, Anesthetics for topical use, Esters of aminobenzoic acid
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Chigg Away Benzocaine 50 mg/mL Lotion is a topical over-the-counter product containing benzocaine, a local anesthetic. This lotion is marketed under FDA's OTC monograph rules for its category rather than as an individually reviewed drug application. Benzocaine is typically used to numb or reduce discomfort on the skin surface where the lotion is applied. Products containing this ingredient are commonly used for minor skin irritation or itch relief.

Supplement & herbal interactions

Some supplements/herbs that may interact with Benzocaine — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Benzocaine (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
82895-0857-05 You're viewing this Main listing 118 mL in 1 BOTTLE, PLASTIC 2022-06-23 Aug 31, 2026 Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Chigg Away 50 mg/mL 82645-0918-94 Pharma 118 ml — — FDA listed —
Chigg Away 50 mg/mLthis 82895-0857-05 Westlake 118 ml — — Discontinued —
HIGHER CONTROL Male Climax Control Lubricating 50 mg/mL 70742-0180-02 Product 60 ml — — FDA listed —
BODY ACTION PRODUCTS Climax Control Gel 50 mg/mL 70742-0282-00 PRODUCT 60 ml — — FDA listed —
BODY ACTION PRODUCTS Endless Love for Men 50 mg/mL 70742-0284-00 PRODUCT 50 ml — — FDA listed —
BODY ACTION PRODUCTS Butt Eze Benzocaine 50 mg/mL 70742-0286-00 PRODUCT 60 ml — — FDA listed —
BODY ACTION PRODUCTS Prolong Lubricating 50 mg/mL 70742-0288-00 PRODUCT 60 ml — — FDA listed —
BODY ACTION PRODUCTS Higher Control Male Climax 50 mg/mL 70742-0292-00 PRODUCT 60 ml — — FDA listed —
Endless Love For Men 50 mg/mL 70742-0360-50 Body 50 ml — — FDA listed —
INTIMALE Benzocaine Delay Gel 50 mg/mL 81923-0369-00 SKINS 15 ml — — FDA listed —
SKINS DELAY Climax Control Benzocaine Gel 50 mg/mL 81923-0365-00 SKINS 3 ml — — FDA listed —
Chigg Away 50 mg/mL 45591-0002-04 Pierson 118 ml — — FDA listed —
BODY ACTION PRODUCTS Anal Glide Extra 50 mg/mL 70742-0287-00 PRODUCT 60 ml — — FDA listed —
POWERECT Benzocaine Male Delay Gel 50 mg/mL 81923-0367-00 SKINS 3 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jun 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerWestlake HB Pharma LLC
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code82895
First marketedJun 2022
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Westlake HB Pharma LLC labeler code 82895

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Other Information 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Use s Relieves itching and discomfort due to nonpoisonous insect bites such as chiggers (redbugs), mosquitoes, ticks, and fleas, no-see-ums, biting flies, fire ants, bees and wasps; swimmers itch.

⏱️ Dosage and Administration 59 words ▾

Directions As an anti-itch: Adults and children 2 yrs. of age and over: apply topically and rub well as needed. Children under 2 years of age: Do not use. As an insect (chigger) repellent: Apply around feet, ankles, waist and to skin under all areas of tight clothing and around all openings in outer clothing. Reapply after heavy respiration.

⚠️ Warnings 76 words ▾

Warnings For external use only. Keep away from eyes or other mucous membranes. Not for prolonged use. For use on intact skin only. Do not use on children younger than 2 yrs. When using this product discontinue use if the condition persists or if rash or irritation develops and consult a doctor. As with all pesticides/drugs, keep out of reach of children. In case of accidental ingestion, contact a physician or poison control center at once.

🧪 Active Ingredient 4 words ▾

Active Ingredient Benzocaine 5%

🧪 Inactive Ingredients 23 words ▾

Inactive Ingredient Cetyl Alcohol, Glycerin, Glyceryl Stearate, Hydroxyethyl Cellulose, Isopropyl Alcohol, Methylparaben, Petrolatum, Propylparaben, Purified Water, Sodium Lauryl Sulfate, Stearic Acid, Sulfur, Triethanolamine..

🎯 Purpose 2 words ▾

Purpose Anesthetic

📄 When Using This Product 24 words ▾

When using this product discontinue use if the condition persists or if rash or irritation develops and consult a doctor. As with all pesticides/drugs,

📄 Keep Out of Reach of Children 20 words ▾

keep out of reach of children. In case of accidental ingestion, contact a physician or poison control center at once.

📄 Other Information 11 words ▾

Other Information Disposal: Do not reuse bottle. Rinse thoroughly before discarding.

📄 Package Label / Principal Display Panel 19 words ▾

PRINCIPAL DISPLAY PANEL NDC 86000-857-05 CHIGG STOP RELIEVES ITCHING REPELS CHIGGERS 4 FL OZ (118 ML) Chigg Stop 2022

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Benzocaine — the ingredient across all brands.

Top reported reactions

Methaemoglobinaemia175
Dyspnoea103
Nausea84
Drug Hypersensitivity75
Asthenia74
Pain74
Vomiting65

Age at onset

Neonate7
Infant3
Child6
Adolescent4
Adult128
Elderly59

Reporter sex

0 reports

Serious outcomes

Hospitalization583
Life-threatening184
Death135
Disabling73
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 129 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Westlake HB Pharma LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 82895-0718-50 · WESTLAKE 82897-0293-00 · GL →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.